MRNA vs NOV · rev $145.0M vs P/E 86, rev $8.74B
Moderna Inc (MRNA) versus NOV Inc. (NOV) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
NOV Inc. (NOV) is a oil & gas equipment & services company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported NOV revenue for 2025-12-31 was $8.74B. Net income was $145.0M. Revenue was down 1.4% from 2024-12-31 to 2025-12-31. NOV currently screens at market cap $7.70B and trailing P/E 85.8.
MRNA currently screens at market cap $24.52B. NOV currently screens at market cap $7.70B and trailing P/E 85.8.
Not investment advice. Open the MRNA and NOV stock pages for the full models.
Not investment advice.